Technology Author: Fuller Wang Editor: Luke Sheehan Sep 07, 2021 09:01 AM (GMT+8)

Through data analysis and event interpretation, we restore the image of the China Concepts Stocks' performance in the first half of 2021.

China Concepts Stocks Overview H1 2021

With the relative control of the pandemic and the economic recovery in the first half of 2021, stock markets are showing impressive prosperity. Growth stocks rose strongly, and the gap between growth and value stocks' performance has narrowed. Impacted by the momentum, most China concepts stocks (CCS) also boomed in the first half of 2021.

Nevertheless, compared with the three major indices, the CCS slightly underperformed within this period. Some popular stocks even bit the dust, such as New Oriental Education and Cloopen Group. In essence, the 'Systematically underperforming' element during this period is closely related to events that happened, including the HFCA act, the aftermath of the Ant Group controversy and the change of the regulatory environment both in China and the United States. Understanding the reasons and analyzing the regulatory reform in both countries is vital for those planning to invest in the CCS.

This report provides a full picture of US-listed Chinese companies' performance. It also focuses on the development and stock price analysis of such companies that went public during the first half of 2021. Through reading our analysis of a large amount of data and key events, investors and analysts interested in CCS can have more in-depth knowledge about the market.

At a glance

A large amount of data shows the IPO situation and individual stock performance in the first half of 2021; we analyze CCS with outstanding performances during this period. In addition, the report also compares various performance data of general shares in previous years with the first half of 2021, including yield, volatility, industry distribution and income map.

market.jpg.jpg

The second part presents a detailed analysis of the key stock market events in the first half of 2021 in detail and gives guidance to investors.

In March 2021, the United States passed the final amendment to HFCAA. In addition to requiring foreign companies to provide three-year audit working papers to the Public Company Accounting Oversight Board (PCAOB), it also requires listed companies to disclose their relationship with the Chinese government. At the same time, in China, with the changes in policies, more and more Internet companies are facing stricter regulatory pressure. Many companies' US-listing plans have been canceled or postponed, and some have been investigated and fined. China and the United States are reshaping their investment regulatory environment, and this report explains why and how.

The report also sorts out all 326 Chinese companies listed in the United States.

market 33.jpg.jpg

For more details, you can purchase the report at EqualOcean.com, or access it through other platforms like Bloomberg Terminal (wire EOI), Dow Jones Factiva, or Refinitiv.

TECHChinaH1 2021Human immunoglobulinZhang Xiaoquan